0000905148-24-002275.txt : 20240816
0000905148-24-002275.hdr.sgml : 20240816
20240816163854
ACCESSION NUMBER: 0000905148-24-002275
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240814
FILED AS OF DATE: 20240816
DATE AS OF CHANGE: 20240816
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Chen Yajing
CENTRAL INDEX KEY: 0001985694
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38205
FILM NUMBER: 241217224
MAIL ADDRESS:
STREET 1: 314 MAIN STREET
STREET 2: 4TH FLOOR, SUITE 100
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Zai Lab Ltd
CENTRAL INDEX KEY: 0001704292
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4560 JINKE ROAD
STREET 2: BLDG. 1, 4F, PUDONG
CITY: SHANGHAI
STATE: F4
ZIP: 201210
BUSINESS PHONE: 862161632588
MAIL ADDRESS:
STREET 1: 4560 JINKE ROAD
STREET 2: BLDG. 1, 4F, PUDONG
CITY: SHANGHAI
STATE: F4
ZIP: 201210
4
1
form4.xml
X0508
4
2024-08-14
0001704292
Zai Lab Ltd
ZLAB
0001985694
Chen Yajing
C/O ZAI LAB LIMITED
314 MAIN STREET, 4TH FLOOR, SUITE 100
CAMBRIDGE
MA
02142
true
Chief Financial Officer
false
American Depositary Shares
2024-08-14
4
M
0
1250
A
14964
D
American Depositary Shares
2024-08-15
4
S
0
422
16.064
D
14542
D
Restricted Share Units
2024-08-14
4
M
0
1250
0
D
American Depositary Shares
1250
3750
D
Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs.
ADSs acquired upon vesting of Restricted Share Units ("RSUs").
Each RSU represents a contingent right to receive one ADS.
These ADSs were sold automatically to cover taxes upon vesting of RSUs.
The RSUs vest in equal annual installments over four years beginning on 08/14/2024, the first anniversary of the date of grant. Vested shares will be delivered in the form of ADSs to the reporting person following vesting.
/s/ Bruce Blefeld, Attorney-in-Fact
2024-08-16